摘要
目的回顾性分析高压氧治疗急性进展性脑梗死的临床疗效。方法选择本院神经内、外科住院的63例急性进展性脑梗死患者,完全随机分为对照组30例,高压氧治疗组33例。2组常规治疗措施包括抗凝、扩血管、营养脑神经细胞等,高压氧治疗组在常规治疗基础上早期给予高压氧治疗,10d为一疗程;对2组进行临床治疗效果评价,统计分析神经功能缺损评分较对照组并进行对比。结果高压氧治疗组神经功能缺损评分较对照组改善显著[治疗后21d为(6.32±2.63)VS(11.43±6.78)],与对照组相比,差异有统计学意义(P〈0.01)。2组临床效果比较,高压氧治疗组显效率高于对照组(71.1%VS50.6%,P〈0.05)o结论高压氧干预进展性脑梗死是一种行之有效的方法,且没有严格受限治疗时间窗的影响,安全性高、副作用小,早期治疗为好。
Objective To explore the therapeutic effects and safety of Hyperbaric Oxygen treating Hyperbaric oxygen (HBO) with acute progressive cerebral infarction (APCI). Methods Sixty-three patients were randomly divided into two groups. The control group ( n = 30) was treated with conventional therapy for APCI, and the treatment group (n = 33 ) was treated with Hyperbaric Oxygen treatment, combined with conventional therapy for A- cute progressive cerebral infarction (ACI) for two weeks. Results After therapy, the scores of Nervous Functional Deficiency were lower than that observed before therapy, especially in the treatment group ( 6.32±2.63 ) vs ( 11. 43 ±6.78)P〈0.01;71.1% vs 50.6% ,P〈0.05). Conclusions Hyperbaric oxygen treatment is safe and effec- tive method for patients with acute progressive cerebral infarction.
出处
《中国医药》
2010年第3期217-219,共3页
China Medicine
关键词
进展性脑梗死
高压氧
神经功能缺损
Acute progressive cerebral infarction
Hyperbaric oxygen
Nervous functional deficiency